W.R. Berkley Corporation (NYSE:WRB) shares decreased -0.02% in last trading session and ended the day at $48.40. WRB has a return on assets of 2.30%. W.R. Berkley Corporation (NYSE:WRB) quarterly performance is -13.40%.
W. R. Berkley Corporation (NYSE:WRB) will release its fourth quarter 2015 earnings after the market closes on Tuesday, February 2, 2016.
Hatteras Financial Corp (NYSE:HTS) ended the last trading day at $11.41. Company weekly volatility is calculated as 4.86% and price to cash ratio as 1.55. Hatteras Financial Corp (NYSE:HTS) showed a weekly performance of -7.91%.
Hatteras Financial Corp. (NYSE:HTS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, MarketBeat reports.
On 21 January, Eli Lilly and Company (NYSE:LLY) shares decreased -1.48% and was closed at $81.40. LLY EPS growth in last 5 year was -10.80%. Eli Lilly and Company (NYSE:LLY) year to date (YTD) performance is -3.39%.
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company’s (NYSE:LLY) Humulin® R U-500 KwikPen®(insulin human injection) 500 units/mL, a pre-filled device containing Humulin R U-500, a highly concentrated formulation of insulin. Humulin R U-500 is the only FDA-approved insulin that is five-times more concentrated than standard U-100 insulin. This insulin is used to treat high blood sugar in people with type 1 and type 2 diabetes who need more than 200 units of insulin per day. The safety and efficacy of Humulin R U-500 used in combination with other insulins or delivered by an insulin infusion pump has not been determined.
Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares decreased -1.26% in last trading session and ended the day at $37.51. ACOR Gross Margin is 80.90% and its has a return on assets of 0.20%. Acorda Therapeutics, Inc. (NASDAQ:ACOR) quarterly performance is 23.39%.
On 19 January, Acorda Therapeutics, Inc. (NASDAQ:ACOR) and Biotie Therapies Corp. have entered into a combination agreement (“Combination Agreement”) whereby Acorda, either directly or through a wholly-owned subsidiary (jointly the “Offeror”), will make a public tender offer in Finland and in the United States to purchase all of the issued and outstanding shares, American Depositary Shares (“ADSs”), stock options, share units and warrants in Biotie that are not owned by Biotie or any of its subsidiaries (the “Tender Offer”).
SolarCity Corporation (NASDAQ:SCTY) caters to the Technology space. It has a net profit margin of -18.70% and weekly performance is -25.70%. On the last day of trading company shares ended up at $31.77. SolarCity Corporation (NASDAQ:SCTY) distance from 50-day simple moving average (SMA50) is -10.63%.
SolarCity (NASDAQ:SCTY) announced SunRaising, a referral program that allows nonprofit organizations to raise funds by encouraging members to adopt solar. Nonprofits can enroll in the SunRaising program now by visiting the registration website. Each time a supporter of a specific SunRaising partner organization signs up, SolarCity will donate $200 to that organization. Homeowners who go solar through a SunRaising partner will also receive their system’s first month of power for free from SolarCity as a thank you for helping their local nonprofit.